Tuberculous monoarthritis after treatment with adalimumab in Crohn's disease

被引:0
作者
Martinez Caselles, Alejandro [1 ]
Martinez Pascual, Cristina [1 ]
Munoz Tornero, Maria [1 ]
Sanchez Torres, Antonio [1 ]
Carballo Alvarez, Fernando [1 ]
机构
[1] Hosp Univ Virgen de la Arrixaca, Serv Aparato Digest, Murcia, Spain
关键词
Tuberculosis monoarthrosis; Adalimumab; Crohn;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:157 / 158
页数:2
相关论文
共 50 条
  • [21] Resources Utilization and Costs the Year Before and After Starting Treatment with Adalimumab in Crohn's Disease Patients
    Saro, Cristina
    Ceballos, Daniel
    Munoz, Fernando
    De la Coba, Cristobal
    Dolores Aguilar, Maria
    Lazaro, Pablo
    Iglesias-Flores, Eva
    Barreiro-de Acosta, Manuel
    Hernandez-Duran, Maria-Dolores
    Barrio, Jesus
    Riestra, Sabino
    Fernandez Salazar, Luis
    INFLAMMATORY BOWEL DISEASES, 2015, 21 (07) : 1631 - 1640
  • [22] Treatment persistence during therapeutic sequences with adalimumab and infliximab in the treatment of Crohn's disease
    Taxonera, Carlos
    Robledo, Pilar
    Rodriguez, Antonio
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2017, 109 (10) : 690 - 693
  • [23] Crohn's Disease in which the Patient Developed Aortitis during Treatment with Adalimumab
    Kiyohara, Hiroki
    Hisamatsu, Tadakazu
    Matsuoka, Katsuyoshi
    Naganuma, Makoto
    Kameda, Hideto
    Seta, Noriyuki
    Takeuchi, Tsutomu
    Kanai, Takanori
    INTERNAL MEDICINE, 2015, 54 (14) : 1725 - 1732
  • [24] Autoimmune Encephalitis During Treatment With Adalimumab: A Case Report in Crohn's Disease
    Fernandez Alvarez, Paula
    Maldonado Perez, Belen
    Castro Laria, Luisa
    Arguelles-Arias, Federico
    INFLAMMATORY BOWEL DISEASES, 2021, 27 (04) : E40 - E41
  • [25] Serial Changes of Serum Cytokines in Crohn's Disease Following Treatment with Adalimumab
    Abiko, Yukito
    Kasugai, Satoshi
    Mizutani, Tomomi
    Chiba, Toshimi
    HEPATO-GASTROENTEROLOGY, 2014, 61 (130) : 357 - 362
  • [26] Adalimumab therapy in a patient with Crohn’s disease with a giant pelvic paraganglioma after chemotherapy
    Mizoshita T.
    Ando M.
    Sagawa H.
    Mori Y.
    Katano T.
    Ozeki K.
    Tanida S.
    Okamoto Y.
    Shimura T.
    Kubota E.
    Kataoka H.
    Kamiya T.
    Joh T.
    Clinical Journal of Gastroenterology, 2017, 10 (3) : 250 - 254
  • [27] Adalimumab in Crohn's disease - A viewpoint by Brian Bressler
    Bressler, Brian
    BIODRUGS, 2007, 21 (02) : 133 - 133
  • [28] Adalimumab Treatment in Pediatric-Onset Crohn's Disease Patients after Infliximab Failure: A Single Center Study
    Song, Won Jae
    Kang, Ben
    Choi, So Yoon
    Choe, Yon Ho
    PEDIATRIC GASTROENTEROLOGY HEPATOLOGY & NUTRITION, 2016, 19 (02) : 116 - 122
  • [29] Clinical status, quality of life, and work productivity in Crohn's disease patients after one year of treatment with adalimumab
    Saro, Cristina
    Ceballos, Daniel
    Munoz, Fernando
    de-la-Coba, Cristobal
    Dolores Aguilar, Maria
    Lazaro, Pablo
    Garcia-Sanchez, Valle
    Hernandez, Mariola
    Barrio, Jesus
    de-Francisco, Ruth
    Fernandez, Luis I.
    Barreiro-de-Acosta, Manuel
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2017, 109 (02) : 122 - 129
  • [30] Benefit of Infliximab Reintroduction after Successive Failure of Infliximab and Adalimumab in Crohn's Disease
    Gagniere, C.
    Beaugerie, L.
    Pariente, B.
    Seksik, P.
    Amiot, A.
    Abitbol, V.
    Allez, M.
    Cosnes, J.
    Sokol, H.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 (04) : 349 - 355